Current Value of Holding

$2.17B

Shares

6.84M

% of Portfolio

0.03%

Average Buy Price

$290

Avg closing price
Price range

18 BlackRock West Pharmaceutical Services Trades

BlackRock acquired 6.84M West Pharmaceutical Services shares worth $2.17B. That's 0.03% of their equity portfolio (412th largest holding). The investor owns 9.51% of the outstanding West Pharmaceutical Services stock. The first West Pharmaceutical Services trade was made in Q4 2020. Since then BlackRock bought shares seven more times and sold shares on ten occasions. The stake costed the investor $1.98B, netting the investor a gain of 9.3% so far.

Avg closing price
Price range
Increased shares by 3.6% (+237k shares) Q1 2026
Avg closing price $246.38
Price range $229.12 - $280.66
Increased shares by 2.2% (+144k shares) Q4 2025
Avg closing price $273.59
Price range $257.77 - $307.25
Sold 2.3% shares (-149k shares) Q3 2025
Avg closing price $242.79
Price range $210.08 - $279.10
Sold 4.7% shares (-325k shares) Q2 2025
Avg closing price $213.49
Price range $190.39 - $227.70
Sold 7.0% shares (-521k shares) Q1 2025
Avg closing price $276.57
Price range $199.11 - $347.87
Increased shares by 2.4% (+173k shares) Q4 2024
Avg closing price $315.45
Price range $286.40 - $344.00
Sold 4.0% shares (-302k shares) Q3 2024
Avg closing price $306.59
Price range $277.16 - $333.30
Increased shares by 0.2% (+16.2k shares) Q2 2024
Avg closing price $353.40
Price range $314.68 - $395.94
Sold 2.8% shares (-215k shares) Q1 2024
Avg closing price $369.91
Price range $338.27 - $413.00
Sold 1.6% shares (-128k shares) Q4 2023
Avg closing price $353.90
Price range $318.29 - $392.21
Sold 0.8% shares (-60.6k shares) Q3 2023
Avg closing price $386.88
Price range $354.90 - $412.41
Sold 0.8% shares (-62k shares) Q2 2023
Avg closing price $357.24
Price range $334.63 - $382.47
Sold 1.5% shares (-120k shares) Q1 2023
Avg closing price $292.19
Price range $232.50 - $346.47
Increased shares by 0.7% (+58.2k shares) Q4 2022
Avg closing price $236.96
Price range $209.34 - $261.61
Increased shares by 0.4% (+34.9k shares) Q3 2022
Avg closing price $304.64
Price range $246.08 - $343.65
Sold 0.3% shares (-26k shares) Q2 2022
Avg closing price $325.39
Price range $280.61 - $420.45
Increased shares by 10.8% (+791k shares) Q1 2022
Avg closing price $391.48
Price range $357.49 - $445.92
New holding (+7.29M shares) Q4 2020
Avg closing price $280.61
Price range $261.16 - $301.66

News about West Pharmaceutical Services, Inc. and BlackRock

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!